open access

Vol 15, No 5 (2010)
Published online: 2010-09-01
Submitted: 2010-03-27
Get Citation

A dosimetric analysis of 6MV versus 15MV photon energy plans for intensity modulated radiation therapy (IMRT) of carcinoma of cervix

Atul Tyagi, Sanjay S. Supe, - Sandeep, Man P. Singh
DOI: 10.1016/j.rpor.2010.08.002
·
Rep Pract Oncol Radiother 2010;15(5):125-131.

open access

Vol 15, No 5 (2010)
Published online: 2010-09-01
Submitted: 2010-03-27

Abstract

Background

Intensity modulated radiotherapy (IMRT) is being used to treat carcinoma of cervix (Ca Cx). Integral dose to normal tissue and increased leakage are the concern about IMRT. 6[[ce:hsp sp="0.25"/]]MV photon beam is a good choice of energy for Ca Cx IMRT treatment.

Aim

The objective of this study was to compare intensity modulated radiotherapy (IMRT) plans generated by 6[[ce:hsp sp="0.25"/]]MV and 15[[ce:hsp sp="0.25"/]]MV photon energies for carcinoma of cervix (Ca Cx) with regards to dosimetric parameters of planning target volume (PTV) and organs at risk (OAR), homogeneity index (HI), conformity index at 98% level (CI 98%), integral dose to normal tissue (NTID) and total number of monitor units (MUs).

Material and methods

A cohort of 16 patients was selected for this study. All patients were to receive a dose of 50[[ce:hsp sp="0.25"/]]Gy in 25 fractions. IMRT plans were generated for both energies using same dose–volume constraints.

Results

Our results show a comparable coverage of planning target volume (PTV) for both energies. Volume of PTV receiving a prescription dose is 97.8[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]0.5% and 98.8[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]0.4% for the 6[[ce:hsp sp="0.25"/]]MV and the 15[[ce:hsp sp="0.25"/]]MV plans. Volume of PTV receiving a dose of 107% is 4.4[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]7.8% and 16.1[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]22.2%. Bladder and rectum mean doses for the 6[[ce:hsp sp="0.25"/]]MV and the 15[[ce:hsp sp="0.25"/]]MV photon plans were 39.8[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]3.0[[ce:hsp sp="0.25"/]]Gy and 40.0[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]3.2[[ce:hsp sp="0.25"/]]Gy, and 35.8[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]3.1[[ce:hsp sp="0.25"/]]Gy and 36.0[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]3.1[[ce:hsp sp="0.25"/]]Gy, respectively. Homogeneity index (HI) for both energies was 1.04. The conformity indices at 98% isodose (CI 98%) were 1.3[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]0.1 and 1.4[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]0.1 for 6[[ce:hsp sp="0.25"/]]MV and 15[[ce:hsp sp="0.25"/]]MV photon plans, respectively.

Conclusions

We conclude that a 6[[ce:hsp sp="0.25"/]]MV photon is a good choice for Ca Cx IMRT as it produces a highly conformal, homogeneous plan with superior target coverage and better OAR sparing.

Abstract

Background

Intensity modulated radiotherapy (IMRT) is being used to treat carcinoma of cervix (Ca Cx). Integral dose to normal tissue and increased leakage are the concern about IMRT. 6[[ce:hsp sp="0.25"/]]MV photon beam is a good choice of energy for Ca Cx IMRT treatment.

Aim

The objective of this study was to compare intensity modulated radiotherapy (IMRT) plans generated by 6[[ce:hsp sp="0.25"/]]MV and 15[[ce:hsp sp="0.25"/]]MV photon energies for carcinoma of cervix (Ca Cx) with regards to dosimetric parameters of planning target volume (PTV) and organs at risk (OAR), homogeneity index (HI), conformity index at 98% level (CI 98%), integral dose to normal tissue (NTID) and total number of monitor units (MUs).

Material and methods

A cohort of 16 patients was selected for this study. All patients were to receive a dose of 50[[ce:hsp sp="0.25"/]]Gy in 25 fractions. IMRT plans were generated for both energies using same dose–volume constraints.

Results

Our results show a comparable coverage of planning target volume (PTV) for both energies. Volume of PTV receiving a prescription dose is 97.8[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]0.5% and 98.8[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]0.4% for the 6[[ce:hsp sp="0.25"/]]MV and the 15[[ce:hsp sp="0.25"/]]MV plans. Volume of PTV receiving a dose of 107% is 4.4[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]7.8% and 16.1[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]22.2%. Bladder and rectum mean doses for the 6[[ce:hsp sp="0.25"/]]MV and the 15[[ce:hsp sp="0.25"/]]MV photon plans were 39.8[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]3.0[[ce:hsp sp="0.25"/]]Gy and 40.0[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]3.2[[ce:hsp sp="0.25"/]]Gy, and 35.8[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]3.1[[ce:hsp sp="0.25"/]]Gy and 36.0[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]3.1[[ce:hsp sp="0.25"/]]Gy, respectively. Homogeneity index (HI) for both energies was 1.04. The conformity indices at 98% isodose (CI 98%) were 1.3[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]0.1 and 1.4[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]0.1 for 6[[ce:hsp sp="0.25"/]]MV and 15[[ce:hsp sp="0.25"/]]MV photon plans, respectively.

Conclusions

We conclude that a 6[[ce:hsp sp="0.25"/]]MV photon is a good choice for Ca Cx IMRT as it produces a highly conformal, homogeneous plan with superior target coverage and better OAR sparing.

Get Citation

Keywords

Carcinoma cervix; IMRT; Photon energy; Conformity index; Integral dose

About this article
Title

A dosimetric analysis of 6MV versus 15MV photon energy plans for intensity modulated radiation therapy (IMRT) of carcinoma of cervix

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 15, No 5 (2010)

Pages

125-131

Published online

2010-09-01

DOI

10.1016/j.rpor.2010.08.002

Bibliographic record

Rep Pract Oncol Radiother 2010;15(5):125-131.

Keywords

Carcinoma cervix
IMRT
Photon energy
Conformity index
Integral dose

Authors

Atul Tyagi
Sanjay S. Supe
- Sandeep
Man P. Singh

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl